journal article·2008-07

Biomimetic modification of the TiO2/glass composite Ecopore with heparinized collagen and the osteoinductive factor BMP-2

M. von Walter, C. Herren, T.J. Gensior, G.C.M. Steffens, B. Hermanns-Sachweh, W. Jahnen-Dechent, M. Rüger, H.J. Erli

Acta Biomaterialia· Volume 4· Issue 4
Publisher page

Abstract

The porous TiO(2)/glass composite Ecopore has potential applications in hard tissue replacement. We describe the modification of Ecopore with the growth factor bone morphogenetic protein-2 (BMP-2) to add osteoinductive properties. Ecopore covalently coated with BMP-2 caused a weak induction of alkaline phosphatase in murine embryonal fibroblasts. In a rabbit bone defect model, BMP-2-coated Ecopore had moderately higher bone apposition rates and ingrown bone quantities at 6 weeks after implantation. To overcome loss of function due to chemical surface coupling, we filled the pore system of Ecopore with heparinized collagen sponge and loaded this secondary matrix with BMP-2. Heparinization of collagen filling increased the BMP-2 loading capacity of the matrix approximately 1.28-fold. Within 96 h, 17.0+/-0.1 and 10.1+/-0.2% of the used BMP-2 was released from non-modified and heparinized Ecopore/collagen, respectively, indicating that the heparin modification retarded BMP-2 release. Revealed by energy-dispersive X-ray spectroscopy analysis of implant cross-sectional areas, BMP-2-loaded Ecopore/collagen had significantly higher bony ingrowth quantities in rabbits, with the heparinized modification yielding the highest value (16.09+/-3.51%, p<0.005) compared with the non-heparinized matrix (10.72+/-4.07%, p<0.05) and the BMP-2-free controls (5.60+/-1.47%). This suggested a beneficial effect of the biomimetic modification of Ecopore with heparinized collagen for bone healing and integration.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Dental Implant Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (16)

Show source-provided references
1. Pfaff E, Aneziris C, Maier HR. Verfahren zur Herstellung poröser keramischer Formkörper, danach hergestellte Formkörper aus Titandioxid sowie deren Verwendungen. German Patent 19605149C2; 2001.
2. In vitro behavior of a porous TiO2/perlite composite and its surface modification with fibronectin10.1016/j.biomaterials.2004.07.066 ↗
3. The effect of surface modification of a porous TiO2/perlite composite on the ingrowth of bone tissue in vivo10.1016/j.biomaterials.2005.08.001 ↗
4. The family of bone morphogenetic proteins10.1046/j.1523-1755.2000.00081.x ↗
5. Overview of bone morphogenetic proteins10.1097/00007632-200208151-00002 ↗
6. Stimulation of bone formation with an in situ setting tricalcium phosphate/rhBMP-2 composite in rats10.1002/jbm.a.10362 ↗
7. Beta-tricalcium phosphate combined with recombinant human bone morphogenetic protein-2: a substitute for autograft, used for packing interbody fusion cages in the canine lumbar spine10.2176/nmc.44.234 ↗
8. Accelerated and improved osteointegration of implants biocoated with bone morphogenetic protein 2 (BMP-2)10.1111/j.1749-6632.2002.tb03067.x ↗
9. Collagenous matrices as release carriers of exogenous growth factors10.1016/j.biomaterials.2003.11.035 ↗
10. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor10.1089/ten.2004.10.1502 ↗
11. Collagen sponges for bone regeneration with rhBMP-210.1016/j.addr.2003.08.010 ↗
12. Extracellular matrix and cytokines: a functional unit10.1155/2000/31748 ↗
13. Growth factors in the extracellular matrix10.1096/fasebj.11.1.9034166 ↗
14. Modification of collagen matrices for enhancing angiogenesis10.1159/000083730 ↗
15. Immobilization of heparin to EDC/NHS-cross-linked collagen. Characterization and in vitro evaluation10.1016/S0142-9612(00)00164-2 ↗
16. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity10.1111/j.1432-1033.1996.0295n.x ↗